Ascendis Pharma A (ASND) Interest Coverage Ratio (QoQ) (2014 - 2026)
Ascendis Pharma A (ASND) Interest Coverage Ratio (QoQ) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Ascendis Pharma A | 15.31 Bn | 14.64 Bn | 268.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1,210.00% |
| Dec 31, 2025 | 117.13% |
| Sep 30, 2025 | 89.75% |
| Jun 30, 2025 | 31.08% |
| Mar 31, 2025 | 100.00% |
| Dec 31, 2024 | -771,902,579.13% |
| Sep 30, 2024 | 156.21% |
| Jun 30, 2024 | -966.16% |
| Mar 31, 2024 | 85.34% |
| Dec 31, 2023 | 20.73% |
| Sep 30, 2023 | 63.67% |
| Jun 30, 2023 | -3.33% |
| Mar 31, 2023 | -103.05% |
| Dec 31, 2022 | 13,758.97% |
| Sep 30, 2022 | 76.71% |
| Jun 30, 2022 | 36.57% |
| Mar 31, 2022 | -108.24% |
| Dec 31, 2021 | 360.51% |
| Sep 30, 2021 | -1,040.80% |
| Jun 30, 2021 | 93.25% |